Table 3 Results of the reliability and subgroup analysis of findings from the 17 DTI studies (18 datasets) with TBSS included in the meta-analysis.
Analysis | Region of FA reduction: Genu of CC | Region of FA reduction: ALIC |
|---|---|---|
Jackknife sensitivity analysis (discarded study) | ||
Excluding Zuo et al. 2012 [20] | Yes | Yes |
Excluding Lai et al. 2014 [21] | Yes | Yes |
Excluding Zhu et al. 2011 [22] | Yes | Yes |
Excluding Versace et al. 2010 [23] | Yes | Yes |
Excluding Choi et al. 2014 [24] | Yes | Yes |
Excluding Murphy et al. 2012 [31] | Yes | Yes |
Excluding Guo et al. 2012 [32] | Yes | Yes |
Excluding Han et al. 2014 [33] | Yes | Yes |
Excluding Hayashi et al. 2014 [34] | Yes | Yes |
Excluding Kieseppa et al. 2010 [35] | Yes | Yes |
Excluding Lyden et al. 2014 [36] | Yes | Yes |
Excluding Olvet et al. nMDD 2014 [37] | Yes | No |
Excluding Olvet et al. sMDD 2014 [37] | Yes | Yes |
Excluding Seok et al. 2013 [38] | Yes | Yes |
Excluding Guo et al. 2012 [39] | Yes | No |
Excluding Korgaonkar et al. 2011 [40] | Yes | Yes |
Excluding Wang et al. 2014 [41] | Yes | Yes |
Excluding Xiao et al. 2015 [42] | Yes | No |
Descriptive analysis of quartiles | ||
First quartile (25%) | Yes | No |
Second quartile (median) | Yes | No |
Third quartile (75%) | No | No |
Subgroup analysis | ||
Studies with first-episode, treatment-naive MDD (n = 7) | No | Yes |
Studies with Medication free MDD (n = 14) | Yes | Yes |
